@ashleynfld101-
The study referred to is this one:
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.The point the authors are making is
not that surgery is as good as RT for clinically diagnosed Stage T3 prostate cancer, but that in the 1987-1997 period "Significantly many patients with cT3 prostate cancer [were] overstaged." Furthermore, they make the point that "most men with pT3 disease (78%) received adjuvant therapy."
Arguably, staging has gotten much better since then. Certainly, MRIs are more accurate, especially with 3 Tesla MRIs becoming more prevalent. I don't know what percent of men who are now clinically staged as cT3 are later downstaged to pT2 on final pathology, but I'd be willing to bet that upstaging far exceeds downstaging. Who would go into surgery based on the likelihood that their PC will be downstaged on final pathology?
Their other point is that with multimodal therapy, that is, with RP+adjuvant RT+ADT, that the oncological outcomes are almost as good as among men clinically diagnosed with cancer confined to the prostate (cT2). That probably stills holds true and is not in dispute. So, for example, with about
50% of T3 patients with biochemical recurrences, and about
half of those cured by adjuvant radiation+ADT, that gives about
a 75% cure rate, which is probably about
the same as for men with high risk, cT2 treated with RP.
The other study they quote - on 15 year outcomes - is irrelevant. Dose escalation in the modern era has dramatically improved outcomes of RT, and multi-modal RT seems to have even better outcomes than dose-escalated EBRT. Also, "all cause mortality" is always worse for RT because men who get RT are, on the average, 10 years older than men who receive RP, so of course they die sooner of some cause after therapy.
But none of that addresses the point of my post, which is that the potential side effects of adjuvant/salvage RT are bad, and it is not a good idea to opt for that at the time the original treatment decision is made.
- Allen